skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,166) Views

Editor in Chief Dr Roger M Pinder

1176-6328


Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder
Ranita Basu, Jaspreet S Brar
Neuropsychiatric Disease and Treatment 2006, 2:241-243
18 February 2006


Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
Adeeb Yacoub, Andrew Francis
Neuropsychiatric Disease and Treatment 2006, 2:235-240
18 February 2006


Cognitive impairment in elderly women: the relative importance of selected genes, lifestyle factors, and comorbidities
Henrik Berg Rasmussen, Yu Z Bagger, László B Tankó, Gerong Qin, Claus Christiansen
Neuropsychiatric Disease and Treatment 2006, 2:227-233
18 February 2006


Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults
Karin F Hoth, Robert H Paul, Leanne M Williams, Carol Dobson-Stone, Elizabeth Todd, Peter R Schofield, John Gunstad, Ronald A Cohen, Evian Gordon
Neuropsychiatric Disease and Treatment 2006, 2:219-225
18 February 2006


Understanding reported cognitive dysfunction in older adults with cardiovascular disease
John Gunstad, Ronald A Cohen, Robert H Paul, David F Tate, Karin F Hoth, Athena Poppas
Neuropsychiatric Disease and Treatment 2006, 2:213-218
18 February 2006


CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
Aoife Hunt, Peter Schönknecht, Markus Henze, Pablo Toro, Uwe Haberkorn, Johannes Schröder
Neuropsychiatric Disease and Treatment 2006, 2:207-212
18 February 2006


Hormones and dementia – a comparative study of hormonal impairment in post-menopausal women, with and without dementia
Olívia Robusto-Leitao, H Ferreira
Neuropsychiatric Disease and Treatment 2006, 2:199-206
18 February 2006


Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting
Luiz Dratcu, Patricia Olowu, Muzafar Hawramy, Charitomeni Konstantinidou
Neuropsychiatric Disease and Treatment 2006, 2:191-197
18 February 2006


Cognitive neuroscience of delusions in aging
Anna EM Holt, Martin L Albert
Neuropsychiatric Disease and Treatment 2006, 2:181-189
18 February 2006


“Getting physical”: the management of neuropsychiatric disorders using novel physical treatments
Gin S Malhi, Colleen Loo, Catherine M Cahill, Jim Lagopoulos, Philip Mitchell, Perminder Sachdev
Neuropsychiatric Disease and Treatment 2006, 2:165-179
18 February 2006


Restless legs syndrome: diagnosis and review of management options
Ruth Byrne, Smita Sinha, K Ray Chaudhuri
Neuropsychiatric Disease and Treatment 2006, 2:155-164
18 February 2006


Bipolar disorders: treatment options and patient satisfaction
Charles Bowden, Vivek Singh
Neuropsychiatric Disease and Treatment 2006, 2:149-153
18 February 2006


The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, A Carlo Altamura
Neuropsychiatric Disease and Treatment 2006, 2:139-148
18 February 2006


Risperidone in the treatment of bipolar mania
Martha Sajatovic, Subramoniam Madhusoodanan, Matthew A Fuller
Neuropsychiatric Disease and Treatment 2006, 2:127-138
18 February 2006


Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?
Chris Fox, Ian D Maidment, Malaz Boustani, Cornelius Katona
Neuropsychiatric Disease and Treatment 2006, 2:121-125
18 February 2006


Editorial: Progress in the treatment of bipolar disorder ||FREE PAPER||
Allan Young
Neuropsychiatric Disease and Treatment 2006, 2:119-120
11 May 2006